ACUIX | VIVAX | ACUIX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 32 years | - |
Gain YTD | 12.894 | 13.482 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.15B | 183B | 1% |
Annual Yield % from dividends | 2.02 | 2.25 | 90% |
Returns for 1 year | 17.49 | 19.29 | 91% |
Returns for 3 years | 3.48 | 19.67 | 18% |
Returns for 5 years | 15.12 | 53.52 | 28% |
Returns for 10 years | 2.56 | 107.49 | 2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VZGRX | 49.10 | 0.51 | +1.05% |
Virtus Zevenbergen Innovative Gr Stk R6 | |||
READX | 11.94 | 0.06 | +0.51% |
Lazard Emerging Markets Eq Advtg R6 | |||
CLWFX | 72.46 | 0.12 | +0.17% |
Columbia Large Cap Growth Inst2 | |||
AMAJX | 10.40 | -0.07 | -0.67% |
American Century Small Cap Dividend R | |||
RPRCX | 8.73 | -0.07 | -0.80% |
Royce Premier Consult |